Document is current
Any future updates will be listed below
-
Authors
Birkeland, Einar
Ferrero, Giulio
Pardini, Barbara
Umu, Sinan U.
Tarallo, Sonia
Bulfamante, Sara
Hoff, Geir
Senore, Carlo
Rounge, Trine B
Naccarati, Alessio
-
Funding
Funding for this research was provided by:
Italian Institute for Genomic Medicine
Compagnia di San Paolo Torino
European Union’s Horizon 2020 research and innovation (825410)
AIRC under IG 2020 (24882)
Norwegian Cancer Society open call (190179)
Cancer Registry of Norways funds
- License Information
-
More Information
Article History
Received: 28 April 2023
Accepted: 25 September 2023
First Online: 3 October 2023
Declarations
:
: The authors declare that they have no competing interests.
: For the MITOS cohort the study design and the informed consent were approved by the local Ethics committee (AOU Città della salute e della Scienza di Torino, Italy). For the NORCCAP and BCSN cohorts, anonymized samples were used. This was approved by the Norwegian Regional Ethics Committee—South-East (REC) projects, S-98052 and 2011/1272, respectively.
